Sleep Apnea clinical trials
136 active trials name this condition (recorded in the registry as “Obstructive Sleep Apnea”) . Describe your situation to see which ones you may be eligible for.
By location
- Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- Pediatric Down Syndrome Post-Approval Study
- Time Restricted Eating in Sleep Apnea
- Severe Label Expansion for EVO Products Trial
- Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives
- Rescue Pharmacotherapy for OSA
- Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA
- DRonabinol Treatment of OSA
- Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils
- Pharmacological Activation of HMN for OSA Aim 2
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
- Endotypic Traits and Obstructive Sleep Apnea Surgery
- App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
- Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety
- Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
- Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
- Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.
- Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea
- Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA
- Low-Tech Treatments for Obstructive Sleep Apnea
- NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
- Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness
- Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
- Long-term Evaluation of a Nasopharyngeal Airway
- Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System
- Cardiometabolic Risk Effects of Short-term Cessation of Neurostimulation Therapy
- Cognition After OSA Treatment Among Native American People (CATNAP)
- Endotype DIrected Treatment for OSA in Down Syndrome
- MedCline Investigational Study for the Treatment of Mild OSA With Positional Therapy
- The Recovery in Stroke Using PAP Study
- Bright Light Therapy for OSA
- Down Syndrome Obstructive Sleep Apnea
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
- Atomoxetine and DAW2022 on OSA Severity
- Trazodone on OSA Endotypes
- Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
- Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
- Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Obstructive Sleep Apnea” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.